Intravenous liposomal irinotecan in metastatic triple-negative breast cancer after ≥ 2 prior lines of chemotherapy: a phase Ib study

Y Ying Fan Q Qingyuan Zhang (Department of Oncology, Harbin Medical University Cancer Hospital, Harbin, China) M Min Yan X Xiujuan Qu Y Yongmei Yin (Tianjin Key Laboratory of Molecular Drug Research, College of Pharmacy) T Tao Sun J Jin Yang Y Ying Wang X Xu Wang Z Zhaofeng Niu X Xinshuai Wang S Sanyuan Sun W Weihong Zhao Y Yanping Liu M Miao Niu X Xuemin Zhao B Binghe Xu (Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing)

Article Details

Volume / Issue Vol. 16, Issue 1
Published January 02, 2025
ISSN 2041-1723
Publisher Nature Portfolio

Journal Info

Nature Communications

Nature Portfolio

ISSN: 2041-1723 Open Access Life Sciences

Authors (17)

Y

Ying Fan

Q

Qingyuan Zhang

Department of Oncology, Harbin Medical University Cancer Hospital, Harbin, China

M

Min Yan

X

Xiujuan Qu

Y

Yongmei Yin

Tianjin Key Laboratory of Molecular Drug Research, College of Pharmacy

T

Tao Sun

J

Jin Yang

Y

Ying Wang

X

Xu Wang

Z

Zhaofeng Niu

X

Xinshuai Wang

S

Sanyuan Sun

W

Weihong Zhao

Y

Yanping Liu

M

Miao Niu

X

Xuemin Zhao

B

Binghe Xu

Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing